abstract |
The present invention discloses the use of a Bcl-2/Bcl-xL inhibitor in the manufacture of a medicament for the treatment of a disease or condition in which inhibition of Bcl-2 or Bcl-xL provides a benefit, e.g., cancer, in an individual in need thereof. In addition, the invention also discloses a pharmaceutical composition containing the Bcl-2/Bcl-xL inhibitor. |